Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Antonio Vena and Matteo Bassetti.
Antonio Vena
Connection Strength
8.367
Matteo Bassetti
  1. Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors. J Clin Med. 2020 Aug 27; 9(9).
    View in: PubMed
    Score: 0.900
  2. Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. Infect Dis Ther. 2018 Mar; 7(1):17-27.
    View in: PubMed
    Score: 0.747
  3. Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther. 2021 Dec; 10(4):1837-1885.
    View in: PubMed
    Score: 0.240
  4. Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med. 2021 08; 15(8):985-992.
    View in: PubMed
    Score: 0.237
  5. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021 Apr 15; 21(1):353.
    View in: PubMed
    Score: 0.235
  6. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021 Feb 03; 10(4).
    View in: PubMed
    Score: 0.232
  7. Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study. Infect Dis Ther. 2021 Mar; 10(1):387-398.
    View in: PubMed
    Score: 0.231
  8. Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship? Microorganisms. 2021 Jan 03; 9(1).
    View in: PubMed
    Score: 0.230
  9. Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations. Microorganisms. 2020 Dec 16; 8(12).
    View in: PubMed
    Score: 0.230
  10. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8):e0237831.
    View in: PubMed
    Score: 0.225
  11. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020 Nov; 26(11):1537-1544.
    View in: PubMed
    Score: 0.224
  12. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020 Oct; 50(10):e13319.
    View in: PubMed
    Score: 0.224
  13. High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection. Eur J Clin Invest. 2020 Oct; 50(10):e13358.
    View in: PubMed
    Score: 0.224
  14. Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19". Open Forum Infect Dis. 2020 Aug; 7(8):ofaa321.
    View in: PubMed
    Score: 0.224
  15. COVID-19: Some clinical questions after the first 4 months. Eur J Clin Invest. 2020 Jul; 50(7):e13326.
    View in: PubMed
    Score: 0.223
  16. A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic. Drugs Context. 2020; 9.
    View in: PubMed
    Score: 0.221
  17. Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul; 26(7):880-894.
    View in: PubMed
    Score: 0.220
  18. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur J Clin Invest. 2020 Mar; 50(3):e13209.
    View in: PubMed
    Score: 0.216
  19. Challenges and research priorities to progress the impact of antimicrobial stewardship. Drugs Context. 2019; 8:212600.
    View in: PubMed
    Score: 0.210
  20. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front Med (Lausanne). 2019; 6:74.
    View in: PubMed
    Score: 0.205
  21. Rational approach in the management of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2018 12; 31(6):578-586.
    View in: PubMed
    Score: 0.199
  22. Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019 Apr; 53(4):408-415.
    View in: PubMed
    Score: 0.199
  23. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018 10; 24(5):385-393.
    View in: PubMed
    Score: 0.197
  24. Management of patients with septic shock due to Candida infection. Hosp Pract (1995). 2018 Dec; 46(5):258-265.
    View in: PubMed
    Score: 0.197
  25. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018; 7:212527.
    View in: PubMed
    Score: 0.192
  26. Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin. Infect Drug Resist. 2018; 11:479-488.
    View in: PubMed
    Score: 0.190
  27. Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality. Transplant Direct. 2017 May; 3(5):e156.
    View in: PubMed
    Score: 0.178
  28. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med. 2017 Apr; 43(4):509-518.
    View in: PubMed
    Score: 0.177
  29. Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study. Crit Care. 2021 06 21; 25(1):214.
    View in: PubMed
    Score: 0.060
  30. Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study. J Clin Med. 2021 Jun 16; 10(12).
    View in: PubMed
    Score: 0.059
  31. Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients. Front Neurol. 2021; 12:674466.
    View in: PubMed
    Score: 0.059
  32. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021; 8:671714.
    View in: PubMed
    Score: 0.059
  33. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. J Geriatr Cardiol. 2021 May 28; 18(5):338-345.
    View in: PubMed
    Score: 0.059
  34. Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol. 2021 09; 93(9):5608-5613.
    View in: PubMed
    Score: 0.059
  35. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity. PLoS Pathog. 2021 04; 17(4):e1009448.
    View in: PubMed
    Score: 0.059
  36. Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study. Crit Care. 2021 03 19; 25(1):111.
    View in: PubMed
    Score: 0.058
  37. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition. 2021 09; 89:111236.
    View in: PubMed
    Score: 0.058
  38. Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia. Crit Care. 2021 02 24; 25(1):81.
    View in: PubMed
    Score: 0.058
  39. Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic. J Fungi (Basel). 2021 Feb 15; 7(2).
    View in: PubMed
    Score: 0.058
  40. Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review. J Clin Med. 2021 Jan 03; 10(1).
    View in: PubMed
    Score: 0.058
  41. Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients. Front Neurol. 2020; 11:602114.
    View in: PubMed
    Score: 0.057
  42. Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy. J Nephrol. 2021 02; 34(1):173-183.
    View in: PubMed
    Score: 0.057
  43. Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? AIDS. 2020 10 01; 34(12):1865-1867.
    View in: PubMed
    Score: 0.057
  44. Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19. Respir Physiol Neurobiol. 2020 11; 282:103529.
    View in: PubMed
    Score: 0.056
  45. Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings. Front Neurol. 2020; 11:845.
    View in: PubMed
    Score: 0.056
  46. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020 08; 279:103455.
    View in: PubMed
    Score: 0.055
  47. Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
    View in: PubMed
    Score: 0.052
  48. Isavuconazole shortens the QTc interval. Mycoses. 2018 Apr; 61(4):256-260.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.